Summary
Calmodulin-dependent protein kinase III (CaM kinase III, elongation factor-2 kinase) is a unique member of the Ca2+/CaM-dependent protein kinase family. Activation of CaM kinase III leads to the selective phosphorylation of elongation factor 2 (eEF-2) and transient inhibition of protein synthesis. Recent cloning and sequencing of CaM kinase III revealed that this enzyme represents a new superfamily of protein kinases. The activity of CaM kinase III is selectively activated in proliferating cells; inhibition of the kinase blocked cells in G0/G1-S and decreased viability. To determine the significance of CaM kinase III in breast cancer, we measured the activity of the kinase in human breast cancer cell lines as well as in fresh surgical specimens. The specific activity of CaM kinase III in human breast cancer cell lines was equal to or greater than that seen in a variety of cell lines with similar rates of proliferation. The specific activity of CaM kinase III was markedly increased in human breast tumour specimens compared with that of normal adjacent breast tissue. The activity of this enzyme was regulated by breast cancer mitogens. In serum-deprived MDA-MB-231 cells, the combination of insulin-like growth factor I (IGF-I) and epidermal growth factor (EGF) stimulated cell proliferation and activated CaM kinase III to activities observed in the presence of 10% serum. Inhibition of enzyme activity blocked cell proliferation induced by growth factors. In MCF-7 cells separated by fluorescence-activated cell sorting, CaM kinase III was increased in S-phase over that of other phases of the cell cycle. In summary, the activity of Ca2+/CaM-dependent protein kinase III is controlled by breast cancer mitogens and appears to be constitutively activated in human breast cancer. These results suggest that CaM kinase III may contribute an important link between growth factor/receptor interactions, protein synthesis and the induction of cellular proliferation in human breast cancer.
Similar content being viewed by others
Article PDF
Change history
16 November 2011
This paper was modified 12 months after initial publication to switch to Creative Commons licence terms, as noted at publication
References
Bagaglio, D. M. & Hait, W. N. (1994). Role of calmodulin-dependent phosphorylation of elongation factor 2 in the proliferation of rat glial cells. Cell Growth Differ 5: 1403–1408.
Carlberg, U., Nilsson, A., Skog, S., Palmquist, K. & Nygard, O. (1991). Increased activity of the eEF-2 specific, Ca2+ and calmodulin dependent protein kinase III during the S-phase in Ehrlich ascites cells. Biochem Biophys Res Commun 180: 13472–13474.
Celis, J. E., Madsen, P. & Ryazanov, A. G. (1990). Increased phosphorylation of elongation factor 2 during mitosis in transformed human amnion cells correlates with a decreased rate of protein synthesis. Proc Natl Acad Sci USA 87: 4231–4235.
Chafouleas, J. G., Pardue, R. L. M., Brinkley, B. R., Dedman, J. R. & Means, A. R. (1981). Regulation of intracellular levels of calmodulin and tubulin in normal and transformed cells. Proc Natl Acad Sci USA 78: 996–1000.
Cheng, E. H. C., Gorelick, F. S., Czernik, A. J. & Hait, W. N. (1995). Calcium/calmodulin-dependent binding proteins and kinase activity in murine and human glioblastoma. Cell Growth Differ 6: 615–621.
Fan, H. & Penman, S. (1970). Regulation of protein synthesis in mammalian cells: inhibition of protein synthesis at the level of initiation during mitosis. J Mol Biol 50: 655–656.
Ford, J. M., Prozialeck, W. C. & Hait, W. N. (1989). Structural features determining activity of phenothiazines and related drugs for inhibition of cell growth and reversal of multidrug resistance. Mol Pharmacol 35: 105–115.
Futey, L. M., Medley, Q. G., Cote, G. P. & Egelhoff, T. T. (1995). Structural analysis of myosin heavy chain kinase A from Dictyostelium. J Biol Chem 270: 523–529.
Greenberg, M. E., Hermanowski, A. L. & Ziff, E. B. (1986). Effect of protein synthesis inhibitors on growth factor activation of c-fos, c-myc, and actin gene transcription. Mol Cell Biol 6: 1050–1057.
Gschwendt, M., Muller, H-J, Kielbassa, K., Zang, R., Kittstein, W., Rincke, G. & Marks, F. (1994). Rottlerin, a novel protein kinase inhibitor. Biochem Biophys Res Commun 199: 93–98.
Hait, W. N. & Lee, G. L. (1985). Characterization of the cytotoxic effects of calmodulin inhibitors. Biochem Pharmacol 34: 3973–3978.
Hait, W. N. & Lazo, J. S. (1986). Calmodulin: a potential target for cancer chemotherapeutic agents. J Clin Oncol 4: 994–1012.
Hait, W. N. & DeRosa, W. T. (1988). Calmodulin as a target for chemotherapeutic strategies. Cancer Invest 6: 499–511.
Hait, W. N., Ward, M. D., Trakht, I. N. & Ryazanov, A. G. (1996). Elongation factor-2 kinase: immunological evidence for the existence of tissue-specific isoforms. FEBS Lett 397: 55–60.
Levenson, R. M. & Blackshear, P. J. (1989). Insulin-stimulated protein tyrosine phosphorylation in intact cells evaluated by giant two-dimensional gel electrophoresis. J Biol Chem 264: 19984–19993.
Lu, K. P. & Means, A. R. (1993). Regulation of the cell cycle by calcium and calmodulin. Endocrine Rev 14: 40–58.
MacManus, J. P., Braceland, B. M. & Rixon, R. H. (1981). An increase in calmodulin during growth of normal and cancerous liver in vivo. FEBS Lett 133: 99–102.
Makino, R., Hayashi, K. & Sugimura, T. (1984). c-myc transcript is induced in rat liver at a very early stage of regeneration by cycloheximide treatment. Nature 310: 697–698.
Mischak, H., Goodnight, J., Kolch, W., Martiny-Baron, G., Schaechtle, C., Kazanietz, M. G., Blumberg, P. M., Pierce, J. H. & Mushinski, J. F. (1993). Overexpression of protein kinase C-δ and -ɛ in NIH 3T3 cells induces opposite effects on growth, morphology, anchorage dependence, and tumorigenicity. J Biol Chem 268: 6090–6096.
Muller, R., Bravo, R., Burkhardt, J. & Curran, T. (1984). Induction of c-fos gene and protein by growth factors precedes activation of c-myc. Nature 312: 716–720.
Okumura-Noji, K., Kato, T., Ito, J., Suzuki, T. & Tanaka, R. (1990). Stimulation by glial maturation factor of Ca2+-dependent phosphorylation of Mr 100 protein in rat glioblasts. Neurochem Int 17: 559–571.
Palfrey, H. C., Nairn, A. C., Muldoon, L. & Villereal, M. L. (1987). Rapid activation of calmodulin-dependent protein kinase III in mitogen-stimulated human fibroblasts. J Biol Chem 262: 9785–9792.
Parmer, T. G., Ward, M. D. & Hait, W. N. (1997). Effects of rottlerin, an inhibitor of calmodulin-dependent protein kinase III, on cellular proliferation, viability, and cell cycle distribution in malignant glioma cells. Cell Growth Differ 8: 327–334.
Prostko, C. R., Zhang, C. & Hait, W. N. (1997). The effect of altered cellular calmodulin expression on the growth and viability of C6 glioblastoma cells. Oncology Res 9: 13–17.
Rasmussen, C. D. & Means, A. R. (1987). Calmodulin is involved in regulation of cell proliferation. EMBO J 6: 3961–3968.
Rasmussen, C. D. & Means, A. R. (1989). Calmodulin is required for cell-cycle progression during G1 and mitosis. EMBO J 8: 73–82.
Redpath, N. T., Price, N. T. & Proud, C. G. (1996). Cloning and expression of cDNA encoding protein synthesis elongation factor-2 kinase. J Biol Chem 271: 17547–17554.
Ryazanov, A. G. & Spirin, A. S. (1993). Phosphorylation of elongation factor 2. A mechanism to shut off protein synthesis for reprogramming gene expression. In Translational Regulation of Gene Expression 2, Ilan, J (ed). pp. 433–455, Plenum Press: New York, USA
Ryazanov, A. G., Ward, M. D., Mendola, C. E., Pavur, K. S., Dorovkov, M. V., Wiedmann, M., Erdjument-Bromage, H., Tempst, P., Parmer, T. G., Prostko, C. R., Germino, F. J. & Hait, W. N. (1997). Identification of a new class of protein kinases represented by eukaryotic elongation factor 2 kinase. Proc Natl Acad Sci USA 94: 4884–4889.
Snedecor, G. W. & Cochran, W. G. (1980). Statistical Methods. Iowa State University Press: Iowa, USA
Veigl, M. L., Vanaman, T. C., Brance, M. E. & Sedwick, W. D. (1984). Differences in calmodulin levels of normal and transformed cells as determined by culture conditions. Cancer Res 44: 3184–3189.
Watanabe, T., Ono, Y., Taniyama, Y., Hazama, K., Igarashi, K., Ogita, K., Kikkawa, U. & Nishizuka, Y. (1992). Cell division arrest induced by phorbol ester in CHO cells overexpressing protein kinase C-δ subspecies. Proc Natl Acad Sci USA 89: 10159–10163.
Author information
Authors and Affiliations
Additional information
This work was supported by Grants CA 43888 and CA 57142 from the National Cancer Institute, and generous contribution from the Hyde and Watson Foundation
Rights and permissions
From twelve months after its original publication, this work is licensed under the Creative Commons Attribution-NonCommercial-Share Alike 3.0 Unported License. To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-sa/3.0/
About this article
Cite this article
Parmer, T., Ward, M., Yurkow, E. et al. Activity and regulation by growth factors of calmodulin-dependent protein kinase III (elongation factor 2-kinase) in human breast cancer. Br J Cancer 79, 59–64 (1999). https://doi.org/10.1038/sj.bjc.6690012
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1038/sj.bjc.6690012
Keywords
This article is cited by
-
Rottlerin and genistein inhibit neuroblastoma cell proliferation and invasion through EF2K suppression and related protein pathways
Naunyn-Schmiedeberg's Archives of Pharmacology (2023)
-
FOXM1 plays a role in autophagy by transcriptionally regulating Beclin-1 and LC3 genes in human triple-negative breast cancer cells
Journal of Molecular Medicine (2019)
-
Suppression of eEF-2K-mediated autophagy enhances the cytotoxicity of raddeanin A against human breast cancer cells in vitro
Acta Pharmacologica Sinica (2018)
-
eEF-2 kinase is a critical regulator of Warburg effect through controlling PP2A-A synthesis
Oncogene (2016)
-
New frontiers in translational control of the cancer genome
Nature Reviews Cancer (2016)